Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Native Canine Serum Leucine Rich Alpha-2-Glycoprotein 1 (LRG1)

Cat. No.AP2F117

Product TypeAnimal Proteins

Size 50 µg

Product Overview

BioVenic's Native Canine Serum Leucine Rich Alpha-2-Glycoprotein 1 (LRG1) is a native protein derived from Canine Serum.

Specifications

Type Native Protein
Species Canine
Source Serum
Purity >90% (SDS-PAGE)
Endotoxin < 1.0 EU/µg
Predicted Molecular Weight 38 kDa
Physical State Lyophilized
Formulation 0.24% Tris, 0.29% Sodium chloride.

Target Information

Research has shown that leucine-rich alpha-2 glycoprotein 1 (LRG1) promotes blood vessel formation by regulating context-dependent endothelial TGFβ signalling. LRG1 belongs to the leucine-rich repeat (LRR) protein family, characterized by repeated motifs rich in the amino acid leucine. It is primarily produced by hepatocytes (liver cells) and released into the bloodstream. LRG1 plays a role in the formation of new blood vessels.

Protein Canine Leucine Rich Alpha-2-Glycoprotein 1 (LRG1)
Protein Synonym leucine rich alpha-2-glycoprotein 1; leucine-rich alpha-2-glycoprotein
Gene ID 611876

Shipping and Storage

Store at -20°C. This product is shipped with ice gel pack.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Song, W. & Wang, X. The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure. Biophysical Reviews. 2015, 7: 91-104.
Inquiry Basket